Evidence map›Paper›PMID 37138091›Full record

ArticleDer Nervenarzt2023

[COVID-19 vaccination for people with severe mental diseases : Results of the COVID Ψ outpatient survey and recommendations for psychiatry].

Hauke Felix Wiegand, Mandy Fehr, Miriam Glock, Mike Rueb, Christa Roth-Sackenheim, Sabine Köhler, Oliver Pogarell, Sophia Horster, Katharina Geschke, Oliver Tüscher and 4 more

Open access · bronzeAbstract readEnglish Abstract
In one paragraph

Article in Der Nervenarzt, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Hauke Felix WiegandKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Mandy FehrKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Miriam GlockKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Mike RuebKlinik für Psychiatrie und Psychotherapie, Klinikum der Universität München (LMU), Numssbaumstr. 7, 80336, München, Deutschland.
Christa Roth-SackenheimBerufsverband Deutscher Psychiater, Berlin, Deutschland.
Sabine KöhlerBerufsverband Deutscher Nervenärzte, Berlin, Deutschland.
Oliver PogarellKlinik für Psychiatrie und Psychotherapie, Klinikum der Universität München (LMU), Numssbaumstr. 7, 80336, München, Deutschland.
Sophia HorsterMedizinische Klinik und Poliklinik II, Klinikum der Universität München (LMU), München, Deutschland.
Katharina GeschkeKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Oliver TüscherKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Klaus LiebKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Peter FalkaiKlinik für Psychiatrie und Psychotherapie, Klinikum der Universität München (LMU), Numssbaumstr. 7, 80336, München, Deutschland.
Lars-Peer HölzelKlinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland.
Kristina AdorjanKlinik für Psychiatrie und Psychotherapie, Klinikum der Universität München (LMU), Numssbaumstr. 7, 80336, München, Deutschland. kristina.adorjan@med.uni-muenchen.de.
Johannes Gutenberg University Mainz · DELMU Klinikum · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere mental illnesses are risk factors for SARS-CoV-2-related morbidity and mortality. Vaccination is an effective protection; therefore, high vaccination rates should be a major priority for people with mental illnesses.

objectives(1) Identification of at-risk groups for non-vaccination and structures and interventions needed for widespread vaccination among people with mental illnesses from the perspective of outpatient psychiatrists and neurologists, (2) discussion of the results in the context of the international literature and (3) recommendations derived from them. MATERIAL AND

methodsQualitative content analysis of COVID-19 vaccination-related questions from the COVID Ψ online survey of n = 85 psychiatrists and neurologists in Germany.

resultsIn the survey, people with schizophrenia, severe lack of drive, low socioeconomic status and homelessness were seen as risk groups for non-vaccination. Increased and targeted information, education, addressing and motivation and easily accessible vaccination offers by general practitioners, psychiatrists, and neurologists as well as complementary institutions were considered as important interventions. DISCUSSION: COVID-19 vaccinations as well as information, motivation and access support should be systematically offered by as many institutions of the psychiatric, psychotherapeutic and complementary care systems in Germany as possible.

Indexed as

COVID-19Mental DisordersPsychiatryCOVID-19 VaccinesHumansOutpatientsSARS-CoV-2COVID-19 VaccinesCOVID-19COVID-19 vaccinationSARS-CoV‑2 infectionSevere mental illnessVaccination preparedness

Identifiers

PMID37138091
PMCPMC10155662
OpenAlexW4367849621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.